Catalyst Wire Dossier Catalyst Wire Dossier

Tumor Polypeptide DC-CTL

· Zhengzhou Revo-Gene Technology Co., LTD
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tumor Polypeptide DC-CTL, covering 2025-02-10 to 2025-02-10. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of Tumor Polypeptide DC-CTL in the Treatment of Solid Tumors [NA]

See pricing